Kevin Fischbeck
Stock Analyst at B of A Securities
(4.08)
# 497
Out of 5,124 analysts
188
Total ratings
66.42%
Success rate
6.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Buy | $32 → $35 | $34.01 | +2.93% | 2 | Dec 9, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Underperform | $22 → $13 | $13.37 | -2.77% | 9 | Dec 3, 2025 | |
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $8.94 | +11.86% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $193.94 | +54.69% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $338.98 | +9.15% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $276.65 | +40.97% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $20.30 | -11.33% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $140.83 | -0.59% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $201.37 | +11.73% | 8 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $105.39 | +51.82% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $30 | $38.46 | -22.00% | 13 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $215 → $185 | $218.56 | -15.36% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $501.69 | -18.28% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $0.65 | +362.96% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $131.72 | +233.28% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $10.65 | -38.97% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $21.74 | -66.65% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $292.05 | +19.84% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $13.56 | +231.86% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.15 | +74.60% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $15.69 | +123.07% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.13 | +369.48% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $8.69 | -13.69% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $20.89 | - | 3 | Sep 6, 2019 |
Option Care Health
Dec 9, 2025
Maintains: Buy
Price Target: $32 → $35
Current: $34.01
Upside: +2.93%
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Underperform
Price Target: $22 → $13
Current: $13.37
Upside: -2.77%
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $8.94
Upside: +11.86%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $193.94
Upside: +54.69%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $338.98
Upside: +9.15%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $276.65
Upside: +40.97%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $20.30
Upside: -11.33%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $140.83
Upside: -0.59%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $201.37
Upside: +11.73%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $105.39
Upside: +51.82%
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $38.46
Upside: -22.00%
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $218.56
Upside: -15.36%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $501.69
Upside: -18.28%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $0.65
Upside: +362.96%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $131.72
Upside: +233.28%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $10.65
Upside: -38.97%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $21.74
Upside: -66.65%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $292.05
Upside: +19.84%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $13.56
Upside: +231.86%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.15
Upside: +74.60%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $15.69
Upside: +123.07%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.13
Upside: +369.48%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $8.69
Upside: -13.69%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $20.89
Upside: -